V. Van Houten and G.J. Mulder
@Fcpm Iii Services B.v.
Latest period2024 - Q3ReportedManaged Assets$582.318MTotal holdings7
Assets growth rate-14.12%Assets growth rate (2-Q avg)-9.12%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Fcpm Iii Services B.v.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 7 positions.
Assets under management
The assets under management (AUM) of Fcpm Iii Services B.v. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 582.318M in assets, with a quarterly growth rate of -14.12% and a 2-quarter average growth rate of -9.12%. The portfolio is managed by V. Van Houten and G.J. Mulder, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
DYNDyne Therapeutics Inc
| 36.73% | $213.87M 5.954M shares@ $35.92 avg price | Decreased -24.1% |
NAMSNewamsterdam Pharma Company
| 33.73% | $196.402M 11.831M shares@ $16.61 avg price | |
ENGNEngene Holdings Inc
| 9.84% | $57.274M 8.678M shares@ $6.6 avg price | |
REPLReplimune Group Inc
| 9.16% | $53.336M 4.866M shares@ $10.96 avg price | |
BCYCBicycle Therapeutics Plc
| 9.1% | $52.953M 2.34M shares@ $22.63 avg price | Increased 10.23% |
ENGNWEngene Holdings Inc
| 1.04% | $6.044M 2.878M shares@ $2.11 avg price | |
ACHLAchilles Therapeutics Plc
| 0.42% | $2.438M 2.39M shares@ $1.02 avg price |